Page 41 - BH-2-3

Brain & Heart Digital tools for stroke and bleeding risk in AF

8. van der Endt VHW, Milders J, Penning de Vries BBL, doi: 10.1001/jama.285.22.2864
et al. Comprehensive comparison of stroke risk score 18. Fuster V, Rydén LE, Cannom DS, et al. 2011 ACCF/AHA/
performance: A systematic review and meta-analysis HRS focused updates incorporated into the ACC/AHA/ESC
among 6 267 728 patients with atrial fibrillation. Europace. 2006 guidelines for the management of patients with atrial
2022;24(11):1739-1753.
fibrillation: A report of the American College of Cardiology
doi: 10.1093/europace/euac096 Foundation/American Heart Association Task Force on
practice guidelines. Circulation. 2011;123(10):e269-e367.
9. Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM.
Influence of etiology of atrial fibrillation on incidence of doi: 10.1161/CIR.0b013e318214876d
systemic embolism. Am J Cardiol. 1977;40(4):509-513.
19. Wang TJ, Massaro JM, Levy D, et al. A risk score for
doi: 10.1016/0002-9149(77)90064-9 predicting stroke or death in individuals with new-onset
atrial fibrillation in the community: The Framingham Heart
10. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major
contributor to stroke in the elderly. The Framingham Study. Study. JAMA. 2003;290(8):1049-1056.
Arch Intern Med. 1987;147(9):1561-1564. doi: 10.1001/jama.290.8.1049
11. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, 20. Gage BF, van Walraven C, Pearce L, et al. Selecting
Wolf PA. Independent risk factors for atrial fibrillation in patients with atrial fibrillation for anticoagulation: Stroke
a population-based cohort: The Framingham heart study. risk stratification in patients taking aspirin. Circulation.
JAMA. 1994;271(11):840-844. 2004;110(16):2287-2292.
doi: 10.1001/jama.1994.03510350050036 doi: 10.1161/01.CIR.0000145172.55640.93
12. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger 21. Rietbrock S, Heeley E, Plumb J, van Staa T. Chronic atrial
RW. Factors associated with ischemic stroke during aspirin fibrillation: Incidence, prevalence, and prediction of stroke
therapy in atrial fibrillation: Analysis of 2012 participants using the Congestive heart failure, Hypertension, Age >75,
in the SPAF I-III clinical trials. The Stroke Prevention Diabetes mellitus, and prior Stroke or transient ischemic
in Atrial Fibrillation (SPAF) Investigators. Stroke. attack (CHADS2) risk stratification scheme. Am Heart J.
1999;30(6):1223-1229. 2008;156(1):57-64.
doi: 10.1161/01.str.30.6.1223 doi: 10.1016/j.ahj.2008.03.010
13. Stroke Prevention in Atrial Fibrillation Investigators. 22. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM.
Stroke prevention in atrial fibrillation study. Final results. Refining clinical risk stratification for predicting stroke
Circulation. 1991;84(2):527-539. and thromboembolism in atrial fibrillation using a novel
risk factor-based approach: The euro heart survey on atrial
doi: 10.1161/01.cir.84.2.527
fibrillation. Chest. 2010;137(2):263-272.
14. Stroke Prevention in Atrial Fibrillation Investigators.
Warfarin versus aspirin for prevention of thromboembolism doi: 10.1378/chest.09-1584
in atrial fibrillation: Stroke Prevention in Atrial Fibrillation 23. Friberg L, Rosenqvist M, Lip GYH. Evaluation of
II Study. Lancet. 1994;343(8899):687-691. risk stratification schemes for ischaemic stroke and
bleeding in 182 678 patients with atrial fibrillation: The
doi: 10.1016/S0140-6736(94)91577-6
Swedish Atrial Fibrillation cohort study. Eur Heart J.
15. Stroke Prevention in Atrial Fibrillation Investigators. 2012;33(12):1500-1510.
Adjusted-dose warfarin versus low-intensity, fixed-dose
warfarin plus aspirin for high-risk patients with atrial doi: 10.1093/eurheartj/ehr488
fibrillation: Stroke Prevention in Atrial Fibrillation III 24. Chen LY, Norby FL, Chamberlain AM, et al. CHA2DS2-
randomised clinical trial. Lancet. 1996;348(9028):633-638. VASc score and stroke prediction in atrial fibrillation in
whites, blacks, and hispanics. Stroke. 2019;50(1):28-33.
doi: 10.1016/S0140-6736(96)03487-3
doi: 10.1161/STROKEAHA.118.021453
16. Risk factors for stroke and efficacy of antithrombotic
therapy in atrial fibrillation: Analysis of pooled data 25. Olesen JB, Lip GYH, Hansen ML, et al. Validation of
from five randomized controlled trials. Arch Intern Med. risk stratification schemes for predicting stroke and
1994;154(13):1449-1457. thromboembolism in patients with atrial fibrillation:
Nationwide cohort study. BMJ. 2011;342:d124.
doi: 10.1001/archinte.1994.00420130036007
doi: 10.1136/bmj.d124
17. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW,
Radford MJ. Validation of clinical classification schemes for 26. European Heart Rhythm Association, European Association
predicting stroke: Results from the national registry of atrial for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for
fibrillation. JAMA. 2001;285(22):2864-2870. the management of atrial fibrillation: The Task Force for the

Volume 2 Issue 3 (2024) 18 doi: 10.36922/bh.3068